Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis- Child C: A Randomized Double Blind Control Trial

NCT03633279 is registered in ClinicalTrials.gov with Dayanand Medical College and Hospital as lead sponsor.

NCT NCT03633279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03633279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Sarcopenia Improves the Muscle Mass and Muscle Strength of Patients With Liver Cirrhosis- Child C: A Randomized Double Blind Control Trial
Lead sponsor
Dayanand Medical College and Hospital
Phase
Phase 3
Overall status
Active, not recruiting
Start date
June 22, 2018
Completion date
September 10, 2025
Enrollment
96 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis